Middle East Healthcare Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SA141H01UKH9
SAR
38.50
-0.46 (-1.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,102.63
2,882.82
2,653.17
2,151.74
1,872.62
1,750.58
1,496.65
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,102.63
2,882.82
2,653.17
2,151.74
1,872.62
1,750.58
1,496.65
Raw Material Cost
2,001.80
1,826.14
1,681.40
1,505.03
1,304.70
1,201.19
1,040.18
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1,543.29
1,393.55
1,301.09
1,173.87
1,034.58
925.64
789.89
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
195.26
224.83
159.81
70.22
52.26
35.93
27.04
Selling and Distribution Expenses
706.11
610.60
603.11
489.42
506.64
438.65
351.27
Other Expenses
-173.86
-161.84
-146.09
-124.41
-108.68
-96.16
-81.69
Total Expenditure (Excl Depreciation)
2,707.91
2,436.74
2,284.51
1,994.45
1,811.34
1,639.84
1,391.45
Operating Profit (PBDIT) excl Other Income
394.7
446.1
368.7
157.3
61.3
110.7
105.19999999999999
Other Income
139.10
42.50
13.28
8.06
10.43
5.87
17.13
Operating Profit (PBDIT)
775.64
704.54
571.24
297.41
212.90
243.83
220.73
Interest
195.26
224.83
159.81
70.22
52.26
35.93
27.04
Exceptional Items
4.92
47.72
-30.68
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
1,100.83
1,056.68
971.77
646.72
567.92
549.39
456.46
Depreciation
245.95
216.75
189.81
145.97
141.41
127.22
98.41
Profit Before Tax
339.35
310.69
190.94
81.22
19.23
80.69
95.28
Tax
16.03
26.28
170.44
9.62
7.50
5.50
5.18
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
301.88
282.00
17.04
75.18
17.20
81.99
97.57
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
301.88
282.00
17.04
75.18
17.20
81.99
97.57
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
7.58
1.88
3.46
-3.58
-5.47
-6.81
-7.46
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
309.46
283.89
20.50
71.60
11.73
75.19
90.11
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
1,872.36
1,626.11
1,319.61
1,364.96
1,257.55
1,231.73
1,522.72
Earnings per share (EPS)
3.28
3.06
0.19
0.82
0.19
0.89
1.06
Diluted Earnings per share
3.28
3.06
0.19
0.82
0.19
0.89
1.06
Operating Profit Margin (Excl OI)
12.59%
15.45%
13.88%
6.66%
3.26%
6.33%
7.03%
Gross Profit Margin
18.86%
18.3%
14.35%
10.56%
8.58%
11.88%
12.94%
PAT Margin
9.73%
9.78%
0.64%
3.49%
0.92%
4.68%
6.52%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 7.62% vs 8.65% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 9.02% vs 1,284.88% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -3.85% vs 18.64% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -13.12% vs 40.68% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Middle East Healthcare Co. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(SAR)
Change(%)
Net Sales
3,102.63
0
3,102.63
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,102.63
0
3,102.63
Raw Material Cost
2,001.80
0
2,001.80
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
1,543.29
0
1,543.29
Power Cost
0
0
0.00
Manufacturing Expenses
195.26
0
195.26
Selling and Distribution Expenses
706.11
0
706.11
Other Expenses
-173.86
0.00
-173.86
Total Expenditure (Excl Depreciation)
2,707.91
0
2,707.91
Operating Profit (PBDIT) excl Other Income
394.72
0.00
394.72
Other Income
139.10
0
139.10
Operating Profit (PBDIT)
775.64
0
775.64
Interest
195.26
0
195.26
Exceptional Items
4.92
0
4.92
Gross Profit (PBDT)
1,100.83
0
1,100.83
Depreciation
245.95
0
245.95
Profit Before Tax
339.35
0
339.35
Tax
16.03
0
16.03
Provisions and contingencies
0
0
0.00
Profit After Tax
301.88
0
301.88
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
301.88
0
301.88
Share in Profit of Associates
0
0
0.00
Minority Interest
7.58
0
7.58
Other related items
0.00
0.00
0.00
Consolidated Net Profit
309.46
0
309.46
Equity Capital
0
0
0.00
Face Value
10.00
0
0.00
Reserves
1,872.36
0
1,872.36
Earnings per share (EPS)
3.28
0
3.28
Diluted Earnings per share
3.28
0
3.28
Operating Profit Margin (Excl OI)
12.59%
0%
0.00
12.59%
Gross Profit Margin
18.86%
0%
0.00
18.86%
PAT Margin
9.73%
0%
0.00
9.73%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 310.26 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 7.62% vs 8.65% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 30.95 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 9.02% vs 1,284.88% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 63.65 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -3.85% vs 18.64% in Dec 2024

Annual - Interest
Interest 19.53 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -13.12% vs 40.68% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.59%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024